Medicine
Glyburide 1.25 mg tablet
Glyburide 1.25 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Glyburide
- Brand
- Sold under the generic name
- Strength
- 1.25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 30 tablets and 18 more
- Manufacturers
- Zydus LifesciencesIndiaAvet PharmaceuticalsIndiaCadila PharmaceuticalsIndiaModavar PharmaceuticalsTeva PharmaceuticalsChartwell RX
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BB01 Glyburide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 May 1984
- Identifiers
- RxCUI 197737, 310534, 310537DailyMed set ID 5d0e406f-285d-4716-8971-82f665345517, 33418bba-c5ea-4c0f-9d28-31dc2724c6c3, 87781ea8-62ec-483c-a4dd-8c965ce59485 +4NDC 65841-832, 23155-056, 68382-656 +5Application ANDA206749, ANDA090937, ANDA203379 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65841-832-01 | Zydus LifesciencesIndia | 2 June 2016 |
| 500 tablet in 1 bottle | 65841-832-05 | Zydus LifesciencesIndia | 2 June 2016 |
| 30 tablet in 1 bottle | 65841-832-06 | Zydus LifesciencesIndia | 2 June 2016 |
| 1000 tablet in 1 bottle | 65841-832-10 | Zydus LifesciencesIndia | 2 June 2016 |
| 90 tablet in 1 bottle | 65841-832-16 | Zydus LifesciencesIndia | 2 June 2016 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 65841-832-77 | Zydus LifesciencesIndia | 2 June 2016 |
| 100 tablet in 1 bottle | 68382-656-01 | Zydus LifesciencesIndia | 2 June 2016 |
| 500 tablet in 1 bottle | 68382-656-05 | Zydus LifesciencesIndia | 2 June 2016 |
| 30 tablet in 1 bottle | 68382-656-06 | Zydus LifesciencesIndia | 2 June 2016 |
| 1000 tablet in 1 bottle | 68382-656-10 | Zydus LifesciencesIndia | 2 June 2016 |
| 90 tablet in 1 bottle | 68382-656-16 | Zydus LifesciencesIndia | 2 June 2016 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 68382-656-77 | Zydus LifesciencesIndia | 2 June 2016 |
| 100 tablet in 1 bottle | 23155-056-01 | Avet PharmaceuticalsIndia | 5 October 2010 |
| 1000 tablet in 1 bottle | 23155-056-10 | Avet PharmaceuticalsIndia | 5 October 2010 |
| 100 tablet in 1 bottle | 71209-009-05 | Cadila PharmaceuticalsIndia | 26 April 2014 |
| 1000 tablet in 1 bottle | 71209-009-11 | Cadila PharmaceuticalsIndia | 26 April 2014 |
| 100 tablet in 1 bottle | 0093-8342-01 | Teva Pharmaceuticals | 30 August 1995 |
| 50 tablet in 1 bottle | 0093-9477-53 | TEVA Pharmaceuticals | 1 May 1984 |
| 30 tablet in 1 bottle | 62135-583-30 | Chartwell RX | 9 May 2023 |
| 100 tablet in 1 bottle | 72241-038-05 | Modavar Pharmaceuticals | 5 October 2021 |
| 1000 tablet in 1 bottle | 72241-038-11 | Modavar Pharmaceuticals | 5 October 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Glyburide
Clinical summary
Glyburide is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets for oral use. MedsAcross supplies Glyburide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GlyburideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Glyburide prescribing information (TEVA Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Amglidia: European public assessment report (EPAR) · European Medicines Agency
Need Glyburide 1.25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.